Non-reproducible prior art post-G 1/23: Novelty versus inventive step (T 1044/23) By Dr Rose Hughes on Tuesday, November 18, 2025 Boards of Appeal enablement epo g1/23 IPKat patents prior use Rose Hughes +
Never Too Late: If you missed the IPKat last week! By Asude Sena Moya on Wednesday, May 14, 2025 #NeverTooLate AI Artificial Intelligence Asude Sena Moya Boards of Appeal copyright designs events General Court opportunities originality patent litigation patents trade marks +
Commercial success is a nothing-burger for the EPO in Wegovy patent inventive step analysis (T 1701/22, Obesity treatment with semaglutide) By Dr Rose Hughes on Thursday, May 08, 2025 Boards of Appeal clinical trial epo patents PatKat pharmaceutical IP Rose Hughes +
[GuestPost] G1/24: Tuning in! A take on the state of proceedings before oral proceedings By Dr Rose Hughes on Friday, March 28, 2025 adaptation of description Boards of Appeal claim interpretation description amendments Enlarged Board of Appeal epo G 1/24 Guest post patents PatKat +
G 2/21 applied to software inventions (T 0687/22) By Dr Rose Hughes on Wednesday, March 26, 2025 AI Artificial Intelligence Boards of Appeal epo G1/19 G2/21 patents PatKat Rose Hughes software inventions +
EBA's preliminary opinion in G1/24: "the description and the figures can be referred to in the course of claim interpretation" By Dr Rose Hughes on Wednesday, February 12, 2025 adaptation of description Article 84 EPC Boards of Appeal claim interpretation description amendments Enlarged Board of Appeal epo EPO president G1/24 patents PatKat Rose Hughes +
A new mode of administration is a new specific medical use (but not necessarily inventive) (T 0295/22) By Dr Rose Hughes on Friday, February 07, 2025 #IPKat Boards of Appeal epo PatKat Rose Hughes Second medical use +
No delay following an intervention to an accelerated EPO appeal during parallel UPC proceedings (T 1841/23) By Dr Rose Hughes on Friday, January 31, 2025 Boards of Appeal epo G2/24 patents PatKat Rose Hughes upc +